Introduction: Semaglutide, a medication known for its efficacy in treating type 2 diabetes and obesity, offers a range of remarkable health benefits beyond its primary indications
Other GLP-1 agonists being named in gastroparesis claims include: Wegovy (semaglutide) Mounjaro (tirzepatide) Rybelsus (semaglutide tablets) Saxenda (liraglutide) Trulicity (dulaglutide) Zepbound (tirzepatide) If you were diagnosed with NAION or gastroparesis after using Ozempic or another GLP-1 drug, you may qualify for a lawsuit
Overall, maintaining muscle mass while losing weight with GLP-1 treatments like Semaglutide and Tirzepatide is achievable with the right approach
[2] Willoughby, D., Hewlings, S., & Kalman, D
In long-term trials, reductions in weight and waist size started to plateau around 60 weeks